Back to Browse Journals » Patient Preference and Adherence » Volume 6

The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy

Authors Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I

Published Date April 2012 Volume 2012:6 Pages 323—329

DOI http://dx.doi.org/10.2147/PPA.S29353

Received 20 December 2011, Accepted 21 February 2012, Published 5 April 2012

Michael Taitel1, Jenny Jiang1, Kristi Rudkin2, Susan Ewing2, Ian Duncan
 
1Clinical Outcomes and Analytics, Walgreens, 2Corporate Innovation Team, Walgreens, Deerfield, Illinois, USA

Purpose: To evaluate the impact of a community-based pharmacist-led face-to-face counseling program on medication adherence for patients who were new to therapy (NTT) for statin medications.
Patients and methods: This retrospective cohort study evaluated a program that was implemented in 76 national community pharmacies located in the midwest USA. It consisted of two face-to-face patient counseling sessions with a pharmacist that addressed patient barriers to adherence. A group of 2056 NTT statin patients was identified between September 1, 2010 and October 31, 2010, and was followed for 12 months. The intervention group consisted of 586 patients, and the comparison group comprised 516 patients. Outcomes were measured using the continuous medication possession ratio (MPR), categorical MPR, and medication persistency.
Results: After adjusting for covariates, the intervention group had statistically greater MPR than the comparison group at every month measured. For example, at 12 months the intervention group had a MPR of 61.8% (CI, 54.5%–69.2%) and the comparison group had a MPR of 56.9% (CI, 49.5%–64.3%); this 4.9% difference is significant (P < 0.01). The 12 month categorical MPR also showed significant differences between groups (χ2 = 6.12, P < 0.05); 40.9% of the intervention group and 33.7% of comparison group had a MPR greater than or equal to 80%. Finally, the intervention group had significantly greater persistency with their medication therapy than the comparison group at 60, 90, 120, and 365 days.
Conclusion: Patients who participated in brief face-to-face counseling sessions with a community pharmacist at the beginning of statin therapy demonstrated greater medication adherence and persistency than a comparison group. This brief targeted intervention at the initiation of maintenance drug therapy moderates the high risk of nonadherence and discontinuation; it helps patients establish a routine of daily self-medication and potentially improves their long-term clinical outcomes.

Keywords: community pharmacy, adherence, counseling, motivational interviewing, statins

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Let’s talk about medication: concordance in rating medication adherence among multimorbid patients and their general practitioners

Ose D, Mahler C, Vogel I, Ludt S, Szecsenyi J, Freund T

Patient Preference and Adherence 2012, 6:839-845

Published Date: 28 November 2012

What elements of the patient–pharmacist relationship are associated with patient satisfaction?

AlGhurair SA, Simpson SH, Guirguis LM

Patient Preference and Adherence 2012, 6:663-676

Published Date: 24 September 2012

Patient satisfaction with pharmaceutical care delivery in community pharmacies

Kassam R, Collins JB, Berkowitz J

Patient Preference and Adherence 2012, 6:337-348

Published Date: 18 April 2012

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

Nair KV, Belletti D, Doyle J, Allen R, McQueen R, Saseen J, Griend J, Patel J, McQueen A, Jan S

Patient Preference and Adherence 2011, 5:195-206

Published Date: 29 April 2011

Patient perceptions of pharmacist roles in guiding self-medication of over-the-counter therapy in Qatar

Kerry Wilbur, Samah El Salam, Ebrahim Mohammadi

Patient Preference and Adherence 2010, 4:87-93

Published Date: 13 April 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009